China's CanSino in talks for coronavirus COVID-19 vaccine Phase III trial overseas

11:00:00 PM, Sunday 12th of July 2020 | in miscellaneous

Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday. China's success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countries have agreed to work with it.